NNH — New Nordic Healthbrands AB Income Statement
0.000.00%
Last trade - 00:00- SEK102.84m
- SEK122.14m
- SEK576.36m
Annual income statement for New Nordic Healthbrands AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | SAS | SAS | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 515 | 488 | 534 | 550 | 576 |
| Cost of Revenue | |||||
| Gross Profit | 350 | 319 | 348 | 355 | 370 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 486 | 492 | 537 | 555 | 561 |
| Operating Profit | 28.5 | -4.75 | -3.17 | -4.45 | 15.1 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 28 | -5.17 | -5.92 | -6.76 | 12.5 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 21.3 | -2.82 | -6.2 | -7.7 | 8.2 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 21.3 | -2.82 | -6.2 | -7.7 | 8.2 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 21.3 | -2.82 | -6.19 | -7.7 | 8.2 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 3.44 | -0.456 | -1 | -1.24 | 1.32 |
| Dividends per Share |